DBL CEPHALOTIN SODIUM 1g powder for injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

dbl cephalotin sodium 1g powder for injection vial

juno pharmaceuticals pty ltd - cefalotin sodium, quantity: 1.058 g (equivalent: cefalotin, qty 1 g) - injection, powder for - excipient ingredients: sodium bicarbonate - indications: cephalothin sodium for injection is indicated for the treatment of serious infections caused by susceptible strains of the designated microorganisms in the diseases listed below. culture and susceptibility studies should be performed. however, therapy may be instituted before results of susceptibility studies are obtained (see pharmacology: microbiology). respiratory tract: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, klebsiella, and h. influenzae. skin and soft tissue: infections, including peritonitis, caused by staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, e.coli, pr. mirabilis and klebsiella. genitourinary tract: infections caused by e. coli, pr. mirabilis and klebsiella. septicaemia, including endocarditis: infections caused by s. pneumoniae, staphylococci (penicillinase and nonpenicillinase producing), group a beta-haemolytic streptococci, s.

Ledertrexate New Zealand - English - Medsafe (Medicines Safety Authority)

ledertrexate

wyeth (nz) ltd - methotrexate 2.5 mg/ml;   - solution for injection - 2.5 mg/ml - active: methotrexate 2.5 mg/ml   excipient: sodium chloride sodium hydroxide water for injection

Ledertrexate New Zealand - English - Medsafe (Medicines Safety Authority)

ledertrexate

wyeth (nz) ltd - methotrexate 25 mg/ml;   - solution for injection - 25 mg/ml - active: methotrexate 25 mg/ml   excipient: sodium chloride sodium hydroxide water for injection

Ledertrexate New Zealand - English - Medsafe (Medicines Safety Authority)

ledertrexate

wyeth (nz) ltd - methotrexate 2.5mg (as disodium salt);  ;   - tablet - 2.5 mg - active: methotrexate 2.5mg (as disodium salt)     excipient: lactose monohydrate magnesium stearate sodium hydroxide starch

Ledertrexate 2,5 mg tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ledertrexate 2,5 mg tabl.

pfizer sa-nv - methotrexate disodium 2,74 mg - eq. methotrexate 2,5 mg - tablet - 2,5 mg - methotrexate 2.5 mg - methotrexate; l04ax03 methotrexate

Ledertrexate 5 mg/2 ml inj. sol. i.m./i.v./i.ventricul./i.arter./i.thec. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ledertrexate 5 mg/2 ml inj. sol. i.m./i.v./i.ventricul./i.arter./i.thec. vial

pfizer sa-nv - methotrexate disodium 5,48 mg/2 ml - eq. methotrexate 5 mg/2 ml - solution for injection - 5 mg/2 ml - methotrexate 5 mg - methotrexate; l04ax03 methotrexate

Ledertrexate 7,5 mg/ml inj. sol. i.v./i.m./i.arter./i.thec./i.ventricul./s.c. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ledertrexate 7,5 mg/ml inj. sol. i.v./i.m./i.arter./i.thec./i.ventricul./s.c. pre-filled syr.

pfizer sa-nv - methotrexate sodium 8,23 mg/ml - eq. methotrexate 7,5 mg/ml - solution for injection - 7,5 mg/ml - methotrexate sodium 8.23 mg/ml - methotrexate; l04ax03 methotrexate

Ledertrexate 15 mg/2 ml inj. sol. i.thec./s.c./i.arter./i.ventricul./i.v./i.m. pre-filled syr. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ledertrexate 15 mg/2 ml inj. sol. i.thec./s.c./i.arter./i.ventricul./i.v./i.m. pre-filled syr.

pfizer sa-nv - methotrexate sodium 8,23 mg/ml - eq. methotrexate 7,5 mg/ml - solution for injection - 7,5 mg/ml - methotrexate sodium 8.23 mg/ml - methotrexate; l04ax03 methotrexate

Ledertrexate Concentrate 5000 mg/50 ml inj. sol. (conc.) i.thec./i.arter./i.ventricul./i.v./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ledertrexate concentrate 5000 mg/50 ml inj. sol. (conc.) i.thec./i.arter./i.ventricul./i.v./i.m. vial

pfizer sa-nv - methotrexate disodium 1096,8 mg/10 ml - eq. methotrexate 1000 mg/10 ml - concentrate for solution for injection - 100 mg/ml - methotrexate 100 mg - methotrexate; l04ax03 methotrexate

Ledertrexate Concentrate 1000 mg/10 ml inj. sol. (conc.) i.thec./i.arter./i.ventricul./i.v./i.m. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ledertrexate concentrate 1000 mg/10 ml inj. sol. (conc.) i.thec./i.arter./i.ventricul./i.v./i.m. vial

pfizer sa-nv - methotrexate disodium 1096,8 mg/10 ml - eq. methotrexate 1000 mg/10 ml - concentrate for solution for injection - 100 mg/ml - methotrexate 100 mg/ml - methotrexate; l04ax03 methotrexate